Advanced search
Publication Cover
Journal of Chemotherapy Volume 3, 1991 - Issue 5
Submit an article Journal homepage
5
Views
27
CrossRef citations to date
0
Altmetric
Original Articles

Chemotherapy with 5-Fluorouracil and Streptozotocin in Carcinoid Tumors of Gastrointestinal Origin: Experiences with 13 Patients

R. RidolfiUnità Sanitaria Locale n. 38 Ospedali G.B. Morgagni-L, Pierantoni – Divisione di Oncologia, Forlì, Italy
,
L. AmaducciUnità Sanitaria Locale n. 38 Ospedali G.B. Morgagni-L, Pierantoni – Divisione di Oncologia, Forlì, Italy
,
S. DerniUnità Sanitaria Locale n. 38 Ospedali G.B. Morgagni-L, Pierantoni – Divisione di Oncologia, Forlì, Italy
,
L. FabbriUnità Sanitaria Locale n. 38 Ospedali G.B. Morgagni-L, Pierantoni – Divisione di Oncologia, Forlì, Italy
,
M.P. InnocentiUnità Sanitaria Locale n. 38 Ospedali G.B. Morgagni-L, Pierantoni – Divisione di Oncologia, Forlì, Italy
&
P. VignutelliUnità Sanitaria Locale n. 38 Ospedali G.B. Morgagni-L, Pierantoni – Divisione di Oncologia, Forlì, Italy
Pages 328-331 | Published online: 15 Jul 2016

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

IM Modlin, M Kidd, I Drozdov, Z-L Siddique & BI Gustafsson. (2008) Pharmacotherapy of neuroendocrine cancers. Expert Opinion on Pharmacotherapy 9:15, pages 2617-2626.
Read now

Articles from other publishers (26)

Agostina Onorato, Esteban Fiore, Juan Bayo, Cecilia Casali, María Fernandez‐Tomé, Marcelo Rodríguez, Luciana Domínguez, Josepmaría Argemi, Florencia Hidalgo, Cristian Favre, Mariana García, Catalina Atorrasagasti & Guillermo D. Mazzolini. (2021) SPARC inhibition accelerates NAFLD‐associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism. Liver International 41:7, pages 1677-1693.
Crossref
Pierre Nahon, Manon Allaire, Jean-Charles Nault & Valérie Paradis. (2020) Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma. Hepatic Oncology 7:4.
Crossref
Katharine E.H. Thomas, Brianne A. Voros, J. Philip Boudreaux, Ramcharan Thiagarajan, Eugene A. Woltering & Robert A. Ramirez. (2019) Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma. The Oncologist 24:8, pages 1076-1088.
Crossref
Mark A. Febbraio, Saskia Reibe, Shabnam Shalapour, Geraldine J. Ooi, Matthew J. Watt & Michael Karin. (2019) Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?. Cell Metabolism 29:1, pages 18-26.
Crossref
Angela Lamarca, Emma Elliott, Jorge Barriuso, Alison Backen, Mairéad G. McNamara, Richard Hubner & Juan W. Valle. (2016) Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: A lost cause?. Cancer Treatment Reviews 44, pages 26-41.
Crossref
Francesca Spada, Lorenzo Antonuzzo, Riccardo Marconcini, Davide Radice, Andrea Antonuzzo, Sergio Ricci, Francesco Di Costanzo, Annalisa Fontana, Fabio Gelsomino, Gabriele Luppi, Elisabetta Nobili, Salvatore Galdy, Chiara Alessandra Cella, Angelica Sonzogni, Eleonora Pisa, Massimo Barberis & Nicola Fazio. (2016) Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors. Neuroendocrinology 103:6, pages 806-814.
Crossref
Haider Raza & Annie John. (2012) Streptozotocin-Induced Cytotoxicity, Oxidative Stress and Mitochondrial Dysfunction in Human Hepatoma HepG2 Cells. International Journal of Molecular Sciences 13:5, pages 5751-5767.
Crossref
Daniel B. Brown, Boris Nikolic, Anne M. Covey, Charles W. Nutting, Wael E.A. Saad, Riad Salem, Constantinos T. Sofocleous & Daniel Y. Sze. (2012) Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy. Journal of Vascular and Interventional Radiology 23:3, pages 287-294.
Crossref
R.G. Ahmed. (2011) Evolutionary interactions between diabetes and development. Diabetes Research and Clinical Practice 92:2, pages 153-167.
Crossref
Su-Jung Kim, Jin Won Kim, Sae-Won Han, Do-Youn Oh, Se-Hoon Lee, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Dae Seog Heo & Yung-Jue Bang. (2010) Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy. BMC Cancer 10:1.
Crossref
Toshiya Ochiai, Sosuke Komiyama, Hisashi Ikoma, Takeshi Kubota, Masayoshi Nakanishi, Daisuke Ichikawa, Shojiro Kikuchi, Hitoshi Fujiwara, Chohei Sakakura, Yukihito Kokuba, Teruhisa Sonoyama & Eigo Otsuji. (2010) A case report of metastatic neuroendocrine carcinoma of the right adrenal gland successfully treated with chemotherapy and surgery. International Journal of Clinical Oncology 15:4, pages 423-427.
Crossref
Daniel B. Brown, John F. Cardella, David Sacks, S. Nahum Goldberg, Debra A. Gervais, Dheeraj K. Rajan, Suresh Vedantham, Donald L. Miller, Elias N. Brountzos, Clement J. Grassi & Richard B. Towbin. (2009) Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy. Journal of Vascular and Interventional Radiology 20:7, pages S219-S226.e10.
Crossref
M. Ducreux, É. Baudin & C. Lombard-Bohas. 2008. Tumeurs endocrines thoraciques et digestives. Tumeurs endocrines thoraciques et digestives 215 232 .
Mark E. O’Donnell, Stephen A. Badger, Garth C. Beattie, Jim Carson & W. Ian H. Garstin. (2007) Malignant neoplasms of the appendix. International Journal of Colorectal Disease 22:10, pages 1239-1248.
Crossref
Emilio Bajetta, Laura Catena, Giuseppe Procopio, Sara De Dosso, Ettore Bichisao, Leonardo Ferrari, Antonia Martinetti, Marco Platania, Elena Verzoni, Barbara Formisano & Roberto Bajetta. (2006) Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?. Cancer Chemotherapy and Pharmacology 59:5, pages 637-642.
Crossref
M. E. O'Donnell, J. Carson & W. I. H. Garstin. (2006) Surgical treatment of malignant carcinoid tumours of the appendix. International Journal of Clinical Practice 61:3, pages 431-437.
Crossref
Irvin M. Modlin, Igor Latich, Mark Kidd, Michelle Zikusoka & Geeta Eick. (2006) Therapeutic Options for Gastrointestinal Carcinoids. Clinical Gastroenterology and Hepatology 4:5, pages 526-547.
Crossref
Daniel B. Brown, John F. Cardella, David Sacks, S. Nahum Goldberg, Debra A. Gervais, Dheeraj Rajan, Suresh Vedantham, Donald L. Miller, Elias N. Brountzos, Clement J. Grassi & Richard B. Towbin. (2006) Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy. Journal of Vascular and Interventional Radiology 17:2, pages 225-232.
Crossref
G T Deans & R A J Spence. (1995) Neoplastic lesions of the appendix. British Journal of Surgery 82:3, pages 299-306.
Crossref
E. Bajetta, L. Catena, G. Procopio, E. Bichisao, L. Ferrari, S. Della Torre, S. De Dosso, S. Iacobelli, R. Buzzoni, L. Mariani & J. Rosai. (2005) Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?. Annals of Oncology 16:8, pages 1374-1380.
Crossref
Keith Stuart, Donna E. Levy, Tom Anderson, Constantine A. Axiotis, Janice P. Dutcher, Andrew Eisenberg, John K. Erban & Al Bowen Benson III. (2004) Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group. Investigational New Drugs 22:1, pages 75-81.
Crossref
Silvia Della Torre, Giuseppe Procopio, Alberto Fusi, Laura Catena, Leonardo Ferrari, Paola Nova, Angela Denaro, Ettore Bichisao & Emilio Bajetta. (2018) Current Treatments of Neuroendocrine Tumors Role of Biotherapy and Chemotherapy. Tumori Journal 89:2, pages 111-116.
Crossref
Alejandro D Bolzán & Martha S Bianchi. (2002) Genotoxicity of Streptozotocin. Mutation Research/Reviews in Mutation Research 512:2-3, pages 121-134.
Crossref
B. Eriksson & K. Öberg. 1998. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie 766 789 .
B. Eriksson & K. Öberg. 1995. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie 643 665 .
B. Eriksson & K. Öberg. 1993. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie 299 315 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.